A detailed history of Park Avenue Securities LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Park Avenue Securities LLC holds 10,093 shares of TEVA stock, worth $228,303. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,093
Previous 11,639 13.28%
Holding current value
$228,303
Previous $189,000 3.7%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$15.81 - $18.96 $24,442 - $29,312
-1,546 Reduced 13.28%
10,093 $182,000
Q2 2024

Jul 09, 2024

SELL
$12.78 - $17.4 $75,862 - $103,286
-5,936 Reduced 33.78%
11,639 $189,000
Q1 2024

Apr 10, 2024

BUY
$10.67 - $14.43 $187,525 - $253,607
17,575 New
17,575 $248,000
Q3 2022

Nov 01, 2022

BUY
$6.86 - $11.95 $81,291 - $141,607
11,850 New
11,850 $95,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.